Ocular Therapeutix Announces Strategic Reduction In Force, Eliminates 37 Employees, Or 13% Of Workforce, To Focus On AXPAXLI Clinical Development For Wet Age-Related Macular Degeneration
Ocular Therapeutix Announces Strategic Reduction In Force, Eliminates 37 Employees, Or 13% Of Workforce, To Focus On AXPAXLI Clinical Development For Wet Age-Related Macular Degeneration
ocular therapeutix宣佈戰略性減縮人員，裁員37名員工，佔員工總數的13％，以專注於AXPAXLI濕性年齡相關性黃斑部病變的臨牀發展。
Ocular Therapeutix Announces Strategic Reduction In Force, Eliminates 37 Employees, Or 13% Of Workforce, To Focus On AXPAXLI Clinical Development For Wet Age-Related Macular Degeneration
ocular therapeutix宣佈戰略性裁員，裁員37名員工，佔員工總數的13%，以專注於AXPAXLI溼性年齡相關性黃斑變性的臨床開發
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。